Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Collaborating U.S. universities identify new monoamine reuptake inhibitors

Feb. 17, 2012

Titan Pharmaceuticals reports results from probuphine trial

Feb. 10, 2012

Study identifies mediator of drug-induced liver injury and agent to target it

Jan. 19, 2012

Inverseon announces initial indication for INV-102

Jan. 17, 2012

Herbal flavonoid counteracts alcohol intoxication

Jan. 17, 2012

New metabotropic glutamate mGlu5 receptor antagonists prepared by GlaxoSmithKline

Jan. 4, 2012

Combination therapy for radiation sickness shows promise in mice

Dec. 30, 2011

BioDelivery Sciences reports on confirmatory BEMA-buprenorphine/naloxone trial

Dec. 22, 2011

Lundbeck reports on MAA for Selincro

Dec. 22, 2011

Paladin Labs launches product for digoxin toxicity and overdose in Canada

Dec. 15, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...